Table 4.
Antibiogram report
| Enterobacter cloacae spp cloacae (5) | Enterococcus faecalis (69) | E. faecium (7) | Enterococcus spp(65) | Escherichia coli (868) | Klebsiella ocytoca (15) | |||||||
| S | Total | S | Total | S | Total | S | Total | S | Total | S | Total | |
| Gentamicin | 80% | 5 | 89% | 868 | 100% | 15 | ||||||
| Gentamicin high level (synergy) | 63% | 68 | 100% | 7 | 76% | 63 | ||||||
| Imipenem | 100% | 5 | 100% | 867 | 100% | 15 | ||||||
| Inducible clindamycin resistance | ||||||||||||
| Levofloxacin | 80% | 5 | 59% | 69 | 29% | 7 | 69% | 65 | 79% | 867 | 93% | 15 |
| Linezolid | 99% | 69 | 100% | 7 | 91% | 65 | ||||||
| Moxifloxacin | ||||||||||||
| Nitrofurantoin | 20% | 5 | 100% | 69 | 14% | 7 | 98% | 65 | 97% | 868 | 80% | 15 |
| Oxacillin MIC | ||||||||||||
| Piperacillin/tazobactam | 80% | 5 | 97% | 864 | 100% | 15 | ||||||
| Quinupristin/dalfopristin | 0% | 68 | 100% | 7 | 19% | 64 | ||||||
| Rifampicin | ||||||||||||
| Streptomycin high level (synergy) | 68% | 68 | 86% | 7 | 71% | 63 | 90% | 868 | ||||
| Tetracycline | 25% | 69 | 14% | 7 | 23% | 65 | 75% | 867 | ||||
| Tigecycline | 100% | 68 | 100% | 7 | 100% | 60 | ||||||
| Tobramycin | 100% | 5 | 100% | 15 | ||||||||
| Trimethoprim/sulfamethoxazole | 80% | 5 | 100% | 15 | ||||||||
| Vancomycin | 97% | 69 | 57% | 7 | 98% | 65 | ||||||
S, susceptibility.